Experimental browser for the Atmosphere
Grove Biopharma signs lease at Fulton Labs - https://chicago.urbanize.city/post/grove-biopharma-signs-lease-fulton-labs
May 3, 2025, 12:20 PM
{ "uri": "at://did:plc:itsfoet44icv62twd5t4kxnx/app.bsky.feed.post/3lobdaanvlm2g", "cid": "bafyreihnkmh3ondebuq7bs4pyii5a6dwvfil5helwz4cbw6ry4bojp5rfi", "value": { "text": "Grove Biopharma signs lease at Fulton Labs - https://chicago.urbanize.city/post/grove-biopharma-signs-lease-fulton-labs", "$type": "app.bsky.feed.post", "embed": { "$type": "app.bsky.embed.external", "external": { "uri": "https://chicago.urbanize.city/post/grove-biopharma-signs-lease-fulton-labs", "title": "Grove Biopharma signs lease at Fulton Labs", "description": "Trammell Crow Company has signed a lease with Grove Biopharma for their headquarters and research and development (R&D) lab at 400 North Aberdeen in Chicago’s Fulton Market neighborhood. The preclinical biotechnology startup, which previously operated out of Portal Innovation’s Fulton Labs location, announced recently the close of a $30 million Series A financing round and is now moving into its own space within a 17,000-square-foot Science-Ready Lab suite." } }, "langs": [ "en" ], "facets": [ { "index": { "byteEnd": 119, "byteStart": 45 }, "features": [ { "uri": "https://chicago.urbanize.city/post/grove-biopharma-signs-lease-fulton-labs", "$type": "app.bsky.richtext.facet#link" } ] } ], "createdAt": "2025-05-03T12:20:54.383Z" } }